ALN.AX - Stock quotes

Live Stock Quotes - Symbol Lookup

The symbol you provided : ALN.AX doesn't appear to be registered!

News Headlines for ALN.AX

IMPORTANT: Bing News RSS feed has moved!
table bgColorffffbb border1pxtdGo to thenbspa hrefhttpapi.bing.comrss.aspxSourceNewsampMarketen-USampVersion2.0 ampQueryALN.AXnew RSS pageanbspand renew your subscription.tdtable

High Quality Templates Grown by HVPE for High Performance Wireless Applications
III-V nitride semiconductors are known to be excellent candidates for high-frequency high-power RF power amplification. The key advantages of III-V nitrides over other semiconductor materials are listed below III-V nitrides have large ...

Alnylam Gets New Patent
The LNP platform is being used to develop many programs under the Alnylam 5x15 strategy. These include -TTR02 an RNAi therapeutic that employs a second-generation LNP formulation to treat transthyretin TTR mediated amyloidosis or ATTR and ...

Alnylam to Webcast Conference Call Discussing Fourth Quarter and 2011 Financial Results
The company is leading the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases including -TTR for the treatment of transthyretin-mediated amyloidosis ATTR ...

Aldrin Appoints Thomas Cavanagh as President and Director
VANCOUVER BRITISH COLUMBIA--Marketwire -013112- Aldrin Resource Corp. Aldrin TSX-V .V - News is pleased to announce the appointment of Thomas Cavanagh as President and Director. Mr. Cavanagh has over 30 years of experience in the ...

Alnylam Gets New Patent - Analyst Blog
The LNP platform is being used to develop many programs under the Alnylam 5x15 strategy. These include -TTR02 an RNAi therapeutic that employs a second-generation LNP formulation to treat transthyretin TTR mediated amyloidosis or ATTR and -PCS ...

Notice of Allowance for Alnylam’s Patent Covering Second Generation LNP Platform
As part of its Alnylam 5x15 product strategy Alnylam Pharmaceuticals uses its proprietary second generation lipid nanoparticle delivery platform in development programs such as -TTR02 an RNAi therapeutic that targets PCSK9 for treating ...

Romney campaign targets Santorum
Mitt Romneys front-running campaign on Monday took aim at trailing rival Rick Santorum indicating concern that the conservative Santorum might be poised for a strong showing in this weeks Republican presidential contests. The GOP hopefuls ...

Asahi Kasei Acquires Crystal IS
Tokyo Jan 17 2012 JCN - Asahi Kasei recently acquired all shares of Crystal IS Inc. CIS a US-based venture focused on the development of ultraviolet light emitting diodes UV LEDs using high-quality aluminum nitride substrates making it a ...

Live Stock Quotes